Regeneron RUBY DME-1518

Completed Studies

A randomized, double-masked active-controlled Phase 2 Study of the Efficacy, Safety, and Tolerability of repeated doses of Intravitreal REGN910-3 in patientss DME.

Duration: 36 weeks

This entry was posted in Uncategorized. Bookmark the permalink.